2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report

被引：13

作者：

Li, Philip Kam-Tao ^{[1
]}

Bavanandan, Sunita ^{[2
]}

Mohamed, Rosmawati ^{[3
]}

Szeto, Cheuk-Chun ^{[1
]}

Wong, Vincent Wai-Sun ^{[4
,5
]}

Chow, Kai-Ming ^{[1
]}

Dan, Yock-Young ^{[6
]}

Huang, Chiu-Ching ^{[7
,8
]}

Lai, Ching-Lung ^{[9
,10
]}

Tanwandee, Tawesak ^{[11
]}

Teo, Boon Wee ^{[12
]}

Wong, Grace Lai-Hung ^{[4
,5
]}

Yeoh, Eng-Kiong ^{[13
]}

Iseki, Kunitoshi ^{[14
]}

Leung, Chi-Bon ^{[1
]}

Park, Hyeong Cheon ^{[15
]}

Kanjanabuch, Talerngsak ^{[16
,17
]}

Lu, Wanhong ^{[18
]}

Fung, James ^{[8
,9
,10
]}

Jia, Jidong ^{[19
]}

Kanda, Eiichiro ^{[20
]}

Law, Man-Ching ^{[1
]}

Liu, Hong ^{[21
]}

Loo, Ching-Kong ^{[22
]}

Mak, Siu-Ka ^{[22
]}

Lui, Sing-Leung ^{[23
]}

Tang, Hon-Lok ^{[24
]}

Wang, Angela Yee-Moon ^{[9
]}

Yu, Ming-Lung ^{[25
,26
]}

Cheung, Michael ^{[27
]}

Jadoul, Michel ^{[28
]}

机构：

[1] Chinese Univ Hong Kong, Carol & Richard Yu Peritoneal Dialysis Res Ctr, Prince Wales Hosp, Dept Med & Therapeut,Shatin, Hong Kong, Peoples R China

[2] Hosp Kuala Lumpur, Dept Nephrol, Kuala Lumpur, Malaysia

[3] Univ Malaysia, Dept Med, Fac Med, Kuala Lumpur, Malaysia

[4] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China

[5] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China

[6] Natl Univ Singapore Hosp, Div Gastroenterol & Hepatol, Singapore, Singapore

[7] China Med Univ & Hosp, Div Nephrol, Dept Internal Med, Taichung, Taiwan

[8] China Med Univ & Hosp, Kidney Inst, Dept Internal Med, Taichung, Taiwan

[9] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Peoples R China

[10] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Peoples R China

[11] Mahidol Univ, Div Gastroenterol & Hepatol, Siriraj Hosp, Dept Internal Med,Fac Med, Bangkok, Thailand

[12] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Div Nephrol, Singapore, Singapore

[13] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Hong Kong, Peoples R China

[14] Tomishiro Cent Hosp, Okinawa, Japan

[15] Yonsei Univ, Gangnam Severance Hosp, Dept Internal Med, Coll Med, Seoul, South Korea

[16] Chulalongkorn Univ, Ctr Excellence Kidney Metab Disorders, Bangkok, Thailand

[17] Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand

[18] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Nephrol, Coll Med, Xian, Peoples R China

[19] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China

[20] Kawasaki Med Sch, Dept Med Sci, Okayama, Japan

[21] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Peoples R China

[22] Kwong Wah Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China

[23] Tung Wah Hosp, Dept Med, Hong Kong, Peoples R China

[24] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Peoples R China

[25] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan

[26] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan

[27] Kidney Dis Improving Global Outcomes KDIGO, Brussels, Belgium

[28] Catholic Univ Louvain, Clin Univ St Luc, Brussels, Belgium

来源：

KIDNEY INTERNATIONAL REPORTS | 2020年 / 5卷 / 08期

关键词：

chronic kidney disease; dialysis; direct-acting antiviral; infection control; kidney transplantation; VIRUS-INFECTION; MICRO-ELIMINATION; DIALYSIS PATIENTS; CORE ANTIGEN; HEMODIALYSIS; DACLATASVIR; ASUNAPREVIR; SAFETY; EFFICACY; THERAPY;

D O I：

10.1016/j.ekir.2020.05.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.

引用

页码：1129 / 1138

页数：10

共 50 条

[31] Kidney Disease Improving Global Outcomes (Kdigo) Guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice (Erbp) Position Statement
Locatelli, Francesco
Barany, Peter
Covic, Adrian
De Francisco, Angel
Del Vecchio, Lucia
Goldsmith, David
Hoerl, Walter
London, Gerard
Vanholder, Raymond
Van Biesen, Wim
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (06) : 1346 - 1359
[32] Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
Locatelli, Francesco
Nissenson, Allen R.
Barrett, Brendan J.
Walker, Rowan G.
Wheeler, David C.
Eckardt, Kai U.
Lameire, Norbert H.
Eknoyan, Garabed
KIDNEY INTERNATIONAL, 2008, 74 (10) : 1237 - 1240
[33] Hepatitis B and hepatitis C virus and chronic kidney disease
Fabrizi, F.
Martin, P.
Messa, P.
ACTA GASTRO-ENTEROLOGICA BELGICA, 2010, 73 (04) : 465 - 471
[34] Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Jha, Vivekanand
Arici, Mustafa
Collins, Allan J.
Garcia-Garcia, Guillermo
Hemmelgarn, Brenda R.
Jafar, Tazeen H.
Pecoits-Filho, Roberto
Sola, Laura
Swanepoel, Charles R.
Tchokhonelidze, Irma
Wang, Angela Yee Moon
Kasiske, Bertram L.
Wheeler, David C.
Spasovski, Goce
KIDNEY INTERNATIONAL, 2016, 90 (06) : 1164 - 1174
[35] Management of hepatitis C in patients with chronic kidney disease
Carvalho-Filho, Roberto J.
Feldner, Ana Cristina C. A.
Silva, Antonio Eduardo B.
Ferraz, Maria Lucia G.
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (02) : 408 - 422
[36] Management of hepatitis C in patients with chronic kidney disease
Roberto J Carvalho-Filho
Ana Cristina CA Feldner
Antonio Eduardo B Silva
Maria Lucia G Ferraz
World Journal of Gastroenterology, 2015, (02) : 408 - 422
[37] The French clinician's guide to the Kidney disease: Improving global outcomes (KDIGO) for chronic kidney disease-mineral and bone disorders (CKD-MBD)
Jean, G.
Chazot, C.
NEPHROLOGIE & THERAPEUTIQUE, 2010, 6 (03): : 151 - 157
[38] Coronary atherosclerosis and risk of acute coronary syndromes in chronic kidney disease using angioscopy and the kidney disease: Improving Global Outcomes (KDIGO) classification
Kurihara, Osamu
Okamatsu, Kentaro
Mizuno, Kyoichi
Takano, Masamichi
Yamamoto, Masanori
Kobayashi, Nobuaki
Munakata, Ryo
Murakami, Daisuke
Inami, Shigenobu
Ohba, Takayoshi
Hata, Noritake
Seino, Yoshihiko
Shimizu, Wataru
ATHEROSCLEROSIS, 2015, 243 (02) : 567 - 572
[39] Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Matzke, Gary R.
Aronoff, George R.
Atkinson, Arthur J., Jr.
Bennett, William M.
Decker, Brian S.
Eckardt, Kai-Uwe
Golper, Thomas
Grabe, Darren W.
Kasiske, Bertram
Keller, Frieder
Kielstein, Jan T.
Mehta, Ravindra
Mueller, Bruce A.
Pasko, Deborah A.
Schaefer, Franz
Sica, Domenic A.
Inker, Lesley A.
Umans, Jason G.
Murray, Patrick
KIDNEY INTERNATIONAL, 2011, 80 (11) : 1122 - 1137
[40] Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
Schiffmann, Raphael
Hughes, Derralynn A.
Linthorst, Gabor E.
Ortiz, Alberto
Svarstad, Einar
Warnock, David G.
West, Michael L.
Wanner, Christoph
KIDNEY INTERNATIONAL, 2017, 91 (02) : 284 - 293

← 1 2 3 4 5 →